Search

Margo Rosemary Roberts

from Venice, CA
Age ~70
Get Report
Also known as:
Margo R Roberts, Margo Dr Roberts, Margo P Roberts, Margo H Kedes, Margo R Kedes, Margo R Dean
Related to:
Maureen J Kedes, 62
Connected to:
Abigale J Roberts, 29Abnetta Robertson, 46Adman Roberts, 42Adriene M Robertson, 57Ajee Roberts, 30Aldolphus S Roberts, 54Aleatha M Roberts, 69Alesa R Roberts, 52Alex L Roberts, 55Alexandra R Roberts, 44

Margo Roberts Phones & Addresses

  • Venice, CA
  • 520 N Kilkea Dr, Los Angeles, CA 90048 (650) 468-6141
  • Santa Monica, CA
  • 736 Partridge Ave, Menlo Park, CA 94025 (434) 245-0511
  • 511 Tulip Tree Ct, Charlottesville, VA 22903 (434) 202-7707
  • 1374 Stone Creek Ln #307, Charlottesville, VA 22902 (434) 245-0511
  • 1045 Quail Hollow Ln, Charlottesvle, VA 22901 (434) 245-0511
  • 1374 Stone Creek Ln, Charlottesvle, VA 22902 (434) 202-1494
  • San Francisco, CA
  • 520 N Kilkea Dr, Los Angeles, CA 90048

Business Records

Name / Title
Company / Classification
Phones & Addresses
Margo A. Roberts
Principal
Honestyhomes
Nonclassifiable Establishments
7610 Calle Verde Rd, Pleasanton, CA 94568
Margo A. Roberts
Dependable Property Solutions LLC
Real Estate Investment Purchase Renovate · Nonresidential Building Operator
7610 Calle Verde Rd, Pleasanton, CA 94568
Margo A Roberts
Managing
2228 CORAL GABLES LLC
822 C St #402, Hayward, CA 94543
7610 Calle Verde Rd, Dublin, CA 94568

Publications

Us Patents

Chimeric Chains For Receptor-Associated Signal Transduction Pathways

View page
US Patent:
6407221, Jun 18, 2002
Filed:
Jun 7, 1995
Appl. No.:
08/475442
Inventors:
Daniel J. Capon - Hillsborough CA
Arthur Weiss - Mill Valley CA
Brian A. Irving - San Francisco CA
Margo R. Roberts - San Francisco CA
Krisztina Zsebo - Woodside CA
Assignee:
Cell Genesys, Inc. - Foster City CA
Regents of the University of California - Oakland CA
International Classification:
C07H 2104
US Classification:
536 234, 435 691, 435 697, 4353201, 435325, 435 6, 4352351, 530300, 530350, 536 231, 536 2353, 536 2352
Abstract:
Chimeric proteins and DNA encoding chimeric proteins are provided, where the chimeric proteins are characterized by an extracellular domain capable of binding to a ligand in a non-MHC restricted manner, a transmembrane domain and a cytoplasmic domain capable of activating a signaling pathway. The extracellular domain and cytoplasmic domain are not naturally found together. Binding of ligand to the extracellular domain results in transduction of a signal and activation of a signaling pathway in the cell, whereby the cell may be induced to carry out various functions relating to the signalling pathway. A wide variety of extracellular domains may be employed as receptors, where such domains may be naturally occurring or synthetic. The chimeric DNA may be used to modify lymphocytes as well as hematopoietic stem cells as precursors to a number of important cell types.

Cancer-Associated Antigens And Methods Of Their Identification And Use

View page
US Patent:
7217421, May 15, 2007
Filed:
Jul 6, 2000
Appl. No.:
09/610891
Inventors:
James McArthur - San Carlos CA, US
Dale Ando - Walnut Creek CA, US
Margo Roberts - Charlottesville VA, US
Jonathan Simons - Atlanta GA, US
William Nelson - Towson MD, US
Assignee:
Cell Genesys, Inc. - South San Francisco CA
International Classification:
A61K 35/12
US Classification:
4242771, 424 933, 435371
Abstract:
The present invention provides novel, isolated, tumor-associated antigens, and methods for identifying such antigens in a biological sample, and of screening for the presence of such an antigen in a biological specimen, wherein the tumor antigen identified reacts with serum from a subject treated with a vaccine comprising a cytokine and proliferation-incompetent tumor cells which express the tumor-associated antigen. Also provided are kits for carrying out the methods of the invention.

Cancer-Associated Antigens And Methods Of Their Identification And Use

View page
US Patent:
7226606, Jun 5, 2007
Filed:
Nov 16, 2005
Appl. No.:
11/274856
Inventors:
James McArthur - San Carlos CA, US
Dale Ando - Walnut Creek CA, US
Margo Roberts - Charlottesville VA, US
Jonathan Simons - Atlanta GA, US
William Nelson - Towson MD, US
Assignee:
Cell Genesys, Inc. - South San Francisco CA
International Classification:
A61K 35/12
US Classification:
4242771, 424 933, 435371
Abstract:
The present invention provides novel, isolated, tumor-associated antigens, and methods for identifying such antigens in a biological sample, and of screening for the presence of such an antigen in a biological specimen, wherein the tumor antigen identified reacts with serum from a subject treated with a vaccine comprising a cytokine and proliferation-incompetent tumor cells which express the tumor-associated antigen. Also provided are kits for carrying out the methods of the invention.

Method For Production Of High Titer Virus And High Efficiency Retroviral Mediated Transduction Of Mammalian Cells

View page
US Patent:
7252991, Aug 7, 2007
Filed:
Oct 1, 2002
Appl. No.:
10/260516
Inventors:
Mitchell H. Finer - San Carlos CA, US
Margo R. Roberts - Charlottesville VA, US
Thomas J. Dull - San Francisco CA, US
Krisztina M. Zsebo - Cupertino CA, US
Lu Qin - Lutherville MD, US
Deborah A. Farson - Oakland CA, US
Assignee:
Cell Genesys, Inc. - South San Francisco CA
International Classification:
C12N 15/867
C12N 15/48
C12N 15/63
C12N 15/64
A61K 48/00
US Classification:
4353201, 536 231, 536 2372
Abstract:
The invention provides a novel retroviral packaging system, in which retroviral packaging plasmids and packagable vector transcripts are produced from high expression plasmids after stable or transient transfection in mammalian cells. High titers of recombinant retrovirus are produced in these transfected mammalian cells and can then transduce a mammalian target cell by cocultivation or supernatant infection. The methods of the invention include the use of the novel retroviral packaging plasmids and vectors to transduce primary human cells, including T cells and human hematopoietic stem cells, with foreign genes by cocultivation or supernatant infection at high efficiencies. The invention is useful for the rapid production of high titer viral supernatants, and to transduce with high efficiency cells that are refractory to transduction by conventional means.

Cancer-Associated Antigens And Methods Of Their Identification And Use

View page
US Patent:
7645587, Jan 12, 2010
Filed:
May 2, 2007
Appl. No.:
11/799584
Inventors:
James McArthur - San Carlos CA, US
Dale Ando - Walnut Creek CA, US
Margo Roberts - Charlottesville VA, US
Jonathan Simons - Baltimore MD, US
William Nelson - Towson MD, US
Assignee:
BioSante Pharmaceuticals, Inc. - Lincolnshire IL
John Hopkins University - Baltimore MD
International Classification:
G01N 33/53
US Classification:
435 71
Abstract:
The present invention provides novel, isolated, tumor-associated antigens, and methods for identifying such antigens in a biological sample, and of screening for the presence of such an antigen in a biological specimen, wherein the tumor antigen identified reacts with serum from a subject treated with a vaccine comprising a cytokine and proliferation-incompetent tumor cells which express the tumor-associated antigen. Also provided are kits for carrying out the methods of the invention.

Chimeric Chains For Receptor-Associated Signal Transduction Pathways

View page
US Patent:
20020111474, Aug 15, 2002
Filed:
Jan 16, 2001
Appl. No.:
09/759352
Inventors:
Daniel Capon - Hillsborough CA, US
Arthur Weiss - Mill Valley CA, US
Bryan Irving - San Francisco CA, US
Margo Roberts - San Francisco CA, US
Krisztina Zsebo - Woodside CA, US
International Classification:
C07H021/04
C12P021/02
C12N005/06
C07K014/705
US Classification:
536/023500, 530/350000, 435/069100, 435/325000, 435/320100
Abstract:
Chimeric proteins and DNA encoding chimeric proteins are provided, where the chimeric proteins are characterized by an extracellular domain capable of binding to a ligand in a non-MHC restricted manner, a transmembrane domain and a cytoplasmic domain capable of activating a signaling pathway. The extracellular domain and cytoplasmic domain are not naturally found together. Binding of ligand to the extracellular domain results in transduction of a signal and activation of a signaling pathway in the cell, whereby the cell may be induced to carry out various functions relating to the signalling pathway. A wide variety of extracellular domains may be employed as receptors, where such domains may be naturally occurring or synthetic. The chimeric DNA may be used to modify lymphocytes as well as hematopoietic stem cells as precursors to a number of important cell types.

Chimeric Receptor Molecules For Delivery Of Co-Stimulatory Signals

View page
US Patent:
57121494, Jan 27, 1998
Filed:
Feb 3, 1995
Appl. No.:
8/383749
Inventors:
Margo R. Roberts - San Francisco CA
Assignee:
Cell Genesys, Inc. - Foster City CA
International Classification:
C07K 14705
C07K 1900
C12N 1562
US Classification:
4352523
Abstract:
The present invention is directed to novel chimeric co-stimulatory receptor proteins and DNA sequences encoding these proteins. The chimeric receptors comprise at least three domains in a single chain molecule: an extracellular ligand binding domain, a transmembrane domain and a cytoplasmic co-stimulatory effector function signaling domain that acts synergistically with an effector function signal in the host cell. Novel hybrid co-stimulatory receptor proteins include a second cytoplasmic effector function signaling domain. The invention further relates to expression cassettes containing the nucleic acids encoding the novel chimeric receptors, to host cells expressing the novel chimeric receptors and to methods of using the receptors to co-stimulate effector functions in the cells and for using cells expressing the receptors for treatment of cancer, disease and viral infections.

Chimeric Chains For Receptor-Associated Signal Transduction Pathways

View page
US Patent:
63194945, Nov 20, 2001
Filed:
Jun 7, 1995
Appl. No.:
8/479737
Inventors:
Daniel J. Capon - Hillsborough CA
Arthur Weiss - Mill Valley CA
Brian A. Irving - San Francisco CA
Margo R. Roberts - San Francisco CA
Krisztina Zsebo - Woodside CA
Assignee:
Cell Genesys, Inc. - Foster City CA
International Classification:
C12N 1500
C12N 1563
C12N 1509
A01N 4304
US Classification:
424 9321
Abstract:
Chimeric proteins and DNA encoding chimeric proteins are provided, where the chimeric proteins are characterized by an extracellular domain capable of binding to a ligand in a non-MHC restricted manner, a transmembrane domain and a cytoplasmic domain capable of activating a signaling pathway. The extracellular domain and cytoplasmic domain are not naturally found together. Binding of ligand to the extracellular domain results in transduction of a signal and activation of a signaling pathway in the cell, whereby the cell may be induced to carry out various functions relating to the signalling pathway. A wide variety of extracellular domains may be employed as receptors, where such domains may be naturally occurring or synthetic. The chimeric DNA may be used to modify lymphocytes as well as hematopoietic stem cells as precursors to a number of important cell types.
Control profile
Margo Rosemary Roberts from Venice, CA, age ~70 Get Report